1. Home
  2. RR vs DSGN Comparison

RR vs DSGN Comparison

Compare RR & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$5.45

Market Cap

690.2M

Sector

N/A

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$10.55

Market Cap

579.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
DSGN
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
690.2M
579.9M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
RR
DSGN
Price
$5.45
$10.55
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$6.00
$15.00
AVG Volume (30 Days)
32.2M
342.7K
Earning Date
01-20-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
N/A
Revenue This Year
$147.00
N/A
Revenue Next Year
$37.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.37
$2.60
52 Week High
$7.43
$10.97

Technical Indicators

Market Signals
Indicator
RR
DSGN
Relative Strength Index (RSI) 68.03 60.71
Support Level $3.81 $9.66
Resistance Level $4.85 $10.97
Average True Range (ATR) 0.52 0.78
MACD 0.12 0.09
Stochastic Oscillator 93.18 79.07

Price Performance

Historical Comparison
RR
DSGN

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: